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-Defensin-1, an antimicrobial peptide encoded by the DEFB1 gene, is known to play an
important role in lung mucosal immunity. In our association study we  analyzed three DEFB1
functional polymorphisms −52G>A (rs1799946), −44C>G (rs1800972) and −20G>A (rs11362)
in  92 tuberculosis patients and 286 healthy controls, both from Northeast Brazil: no associ-
ation was found between the studied DEFB1 polymorphisms and the disease. However we
cannot exclude that this lack of association could be due to the low number of subjects
analyzed, as suggested by the low statistical power achieved for the three analyzed SNPs
(values between 0.16 and 0.50).
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Introduction
Mycobacterial diseases are a major health concern, affect-
ing approximately one-third of the world’s population.1 The
most common clinical form of the disease is pulmonary
tuberculosis, a granulomatous disease of the lungs caused by
Mycobacterium tuberculosis. Extrapulmonary tuberculosis may
occur when the bacillus infects other organs.2–4
The general risk of infected individuals to develop the
disease during their lifetime ranges between 5 and 10%.2,3
A possible genetic predisposition to tuberculosis (TB) has
been suggested in several studies.5–8 Moreover evidence
exist that extrapulmonary TB is the result of an underlying
immune defect,4 however, the functional correlation between
genetic polymorphisms and immunologic defect should be yet
unraveled.7
The mucosal immunity of air epithelia is complex, and the
innate immune system, mainly by the mucosal secretion of
antimicrobial peptides gradient, is thought to play an impor-
tant role in defense against M. tuberculosis, although the exact
mechanisms are yet poorly understood.9,10
The human -defensin-1 (hBD-1) is a small (29–47
amino acids) cationic antimicrobial peptide,11 constitutively
expressed in airway epithelia that plays an important role in
mucosal immunity in the lung.12–15 This peptide is encoded
by DEFB1 gene, located at chromosome 8p22-23.16
Three single nucleotide polymorphisms (SNPs), located
at −52G>A (rs1799946), −44C>G (rs1800972) and −20G>A
(rs11362) position in the 5′ untranslated region (UTR) of the
DEFB1 gene have been reported to promote functional alter-
ation of hBD-1 expression in different cell models.17,18 These
SNPs were ﬁrstly described by Dörk and Stuhrmann19 and
have been then associated with chronic obstructive pul-
monary disease,20 increased levels of Candida albicans in
the oral cavity,21 increased risk for Human Immunodeﬁ-
ciency Virus 1 infection,22–25 susceptibility to mycobacterial
diseases8,26 and other diseases.27–31
Considering the possible role of the innate immune sys-
tem in the risk of tuberculosis infection, this study aims
to examine whether functional polymorphisms at 5′UTR in
DEFB1 gene are associated with the occurrence of active
tuberculosis.
Patients  and  methods
Study  population
Ninety-two TB patients were enrolled from ﬁve reference cen-
ter for TB follow up in Recife (Pernambuco, Northeast Brazil):
Hospital das Clínicas – Universidade Federal de Pernambuco
(HC-UFPE), Instituto de Medicina Integral Professor Fernando
Figueira (IMIP), Hospital Barão de Lucena (HBL/US) and Hos-
pital Otávio de Freitas. Of the 92 patients analyzed, 64 (69.6%)
presented with pulmonary TB (36 males and 28 females, mean
age 21 years ± 18.7) and 28 (30.4%) with extrapulmonary TB (17
males and 11 females, mean age 23 years ± 21.7). The diagno-
sis was based on clinical symptoms and radiographic ﬁndings,
along with bacteriological conﬁrmation (culture, smear and/or
polymerase chain reaction) as described by the Diagnostic b i o l o g y 4 7 (2 0 1 6) 389–393
Standards and Classiﬁcation of Tuberculosis in Adults and
Children.32
As control group, we enrolled 286 healthy individ-
uals (163 females/123 males; mean age 27 years ± 20.3),
unrelated to patients, with negative Mantoux test, show-
ing no symptoms of tuberculosis or previous history of
the disease. All patients and control subjects came from
the same geographical area (Pernambuco, Brazil), were all
HIV-1 negative and were not under immunosuppressive
medication.
Since ethnicity is an important issue in genetic analyses,
patients and controls reported their self-declared skin based
ethnic origin. During ethnicity report a health professional
accompanied the procedure guaranteeing the correctness of
the procedure. After ethnicity assessment we  veriﬁed the self-
reported and health professional checked results, by analyzing
in the controls 12 Ancestry informative markers (AIMs) as
recently reported by Coelho et al.33 Absence or extremely
poor correlation between skin based ethnicity and the true
genetic background, as revealed by the 12 AIMs analysis, was
observed. So, we discarded the self-declared skin based eth-
nic origin and considered only the genetic AIMs ﬁndings. In
fact, our studied population consists of a strong admixture of
European-Caucasian, African and South American Amerindi-
ans population, leading the genetic North East Brazilian
composition unique; consequently it is impossible to stratify
our population for ethnicity, being an admixture of around
58% European, 24% African and 18% Amerindian as recently
reported.33
Written informed consent was obtained from the par-
ticipants or their parents. The CPqAM/FIOCRUZ Ethics
Committee (CEP Registration – 55/05) approved the study.
Patients underwent a standardized clinical–epidemiological
questionnaire.
DEFB1  genotyping
Genomic DNA was extracted from whole blood using QIAamp
DNA Blood Kit according to manufacturer instructions
(QIAamp DNA Blood Midi Kit, Qiagen).
The DEFB1 5′UTR polymorphisms −52G>A (rs1799946),
−44C>G (rs1800972) and −20G>A (rs11362) were geno-
typed by direct sequencing, according to Braida
et al.22 Sequences were handled using the 4Peaks
(http://nucleobytes.com/index.php/4peaks) and CodonCode
Aligner software (http://www.codoncode.com/aligner/).
Statistical  analysis
Chi-square test was used to verify the Hardy–Weinberg
equilibrium and the Fisher’s exact test was employed for
pair-wise comparison of allele, genotype and haplotype fre-
quencies using contingency tables as appropriate; only p
values < 0.05 were considered to be signiﬁcant. All the sta-
tistical analyses were carried out using the open-source R
package (http://www.r-project.org). The power of the study
was checked by software G*power software version 3.1.34 Hap-
lotypes were computed using the Arlequin version 3.5.1.335
and Haploview software.36
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Table 1 – Alleles and genotypes distribution of SNPs – in the 5′ untranslated region (UTR) of DEFB1 gene in tuberculosis
patients (TB) and healthy controls (HC) from Northeast Brazil.
SNPs TB patients
n  = 92
Healthy controls
n = 268
p-value,  OR (95% CI)
All pTB All vs. HC pTB  vs. HC
-52G>A (rs1799946)
G  97 (0.53) 68 (0.54) 309 (0.54) Reference Reference
A 87 (0.47) 58 (0.46) 263 (0.46) p = 0.80, 1.05 (0.74–1.49) p = 1.00, 1.00 (0.67–1.50)
GG 29 (0.32) 19 (0.30) 89 (0.31) Reference Reference
GA 39 (0.42) 30 (0.48) 131 (0.46) p = 0.78, 0.91 (0.51–1.65) p = 0.87, 1.07 (0.54–2.15)
AA 24 (0.26) 14 (0.22) 66 (0.23) p = 0.75, 1.11 (0.56–2.19) p = 1.00, 0.99 (0.43–2.26)
GA/AA 63 (0.68) 44(0.70) 197 (0.69) p = 1.00, 0.98 (0.58–1.69) p = 1.00, 1.05 (0.56–2.01)
−44C>G (rs1800972)
C 153 (0.83) 102 (0.81) 491 (0.86) Reference Reference
G 31 (0.17) 24 (0.19) 81 (0.14) p = 0.40, 1.23 (0.75–1.96) p = 0.17, 143 (0.82–2.40)
CC 66 (0.72) 42 (0.67) 213 (0.74) Reference Reference
CG 21 (0.23) 18 (0.29) 65 (0.23) p = 0.89, 1.04 (0.56–1.88) p = 0.29, 1.40 (0.71–2.69)
GG 5 (0.05) 3 (0.05) 8 (0.03) p = 0.32, 2.01 (0.50–7.25) p = 0.40, 1.90 (0.31–8.32)
CG/GG 26 (0.28) 21 (0.34) 73 (0.26) p = 0.59, 1.15 (0.65–1.99) p = 0.21, 1.46 (0.77–2.71)
−20G>A (rs11362)
G 118 (0.64) 82 (0.65) 361 (0.63) Reference Reference
A 66 (0.36) 44 (0.35) 211 (0.37) p = 0.86, 0.96 (0.66–1.37) p = 0.76, 0.92 (0.60–1.40)
GG 39 (0.42) 26 (0.41) 115 (0.40) Reference Reference
GA 40 (0.43) 30 (0.48) 131 (0.46) p = 0.70, 0.90 (0.52–1.54) p = 1.00, 1.01 (0.54–1.90)
AA 13 (0.14) 7 (0.11) 40 (0.14) p = 1.00, 0.96 (0.42–2.06) p = 0.66, 0.77 (0.26–2.02)
GA/AA 53 (0.57) 37 (0.59) 171 (0.60) p = 0.72, 0.91 (0.55–1.52) p = 0.89, 0.96 (0.53–1.74)
pTB, pulmonary tuberculosis; OR, odds ratio; 95% CI, 95% conﬁdence interval; SNP, single nucleotide polymorphism. Reference indicates the
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esults
he genotyping results of the three 5′UTR DEFB1 functional
olymorphisms −52G>A (rs1799946), −44C>G (rs1800972) and
20G>A (rs11362) in TB patients and healthy controls, are
hown in Table 1. All SNPs were in Hardy–Weinberg equilib-
ium for both TB patients and healthy controls.
DEFB1 SNPs allele and genotype frequencies were sim-
lar in TB patients and healthy controls and no signif-
cant difference has been found (p > 0.05), also when TB
atients were stratiﬁed according to the pulmonary form of
isease.
We computed the haplotypes and observed that the three
NPs in the 5′UTR of DEFB1 are in strong linkage disequilibrium
D′ > 0.9), forming four haplotypes (Table 2). However, no sig-
iﬁcant differences were found when comparing TB patients
nd healthy controls (Table 2).
In addition, we  estimated the linkage disequilibrium
nd the possible haplotypes, using Haploview software, for
razilian healthy controls (BRA) and healthy individuals of
frican (AFR), Caucasian (CEU) and Ad Mixed American
AMR) origin, provided by 1000 Genome Project Database
www.1000genomes.org). We noted that DEFB-1 SNPs were
n perfect linkage disequilibrium (D′ = 1.0) and have dif-
erent haplotype distributions in the studied populations
Table 3).The post hoc analysis of the study through the G*power
oftware, indicate the following power for three SNPs: 0.30
−52G>A), 0.5 (−44C>G) and 0.16 (−20G>A).Discussion
In the current study, no association was found between
−52G>A (rs1799946), −44C>G (rs1800972), −20G>A (rs11362)
DEFB1 polymorphisms and TB in a Brazilian population, also
when considering the pulmonary form of the disease.
In a case–control study, Wu  et al.8 analyzed DEFB1 5′UTR
polymorphisms in 102 patients with pulmonary TB and 148
healthy controls of Chinese Han population observing that
the DEFB1 −44C/C genotype was associated with pulmonary
TB susceptibility (OR = 2.096) and the GGG (−52/−44/−20) hap-
lotype was associated with the pulmonary TB protection
(OR = 0.348).
In a recent work, performed on a limited number of
Mexican patients (27 with pulmonary TB and 16 with extra-
pulmonary TB) and controls (n = 49), López Campos et al.37
described an association between DEFB1 −44C>G SNP (CG
genotype in a codominant genetic model) and susceptibility to
extrapulmonary TB, but not with the pulmonary TB, hypoth-
esizing a role for hBD-1 in the ﬁght against M. tuberculosis
outside the lung.
Our ﬁndings have discrepancies with the results obtained
by Wu  et al.8 on Han population and by Lopez Campos et al.37
in Mexicans: we can hypothesize that the differences could be,
at least in part, due to ethnicity, since the frequencies DEFB1
SNPs vary in different populations. According to the NCBI and
HapMap databases,38 for −52 SNP (rs1799946) the frequency
of the ancestral allele is 0.64 in European (CEU), 0.56 in Sub-
Sahara African (YRI) and 0.40 in Asian (HCB); the frequency
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Table 2 – Haplotypes frequency distribution of 5′UTR DEFB SNPs in tuberculosis patients (TB) and healthy controls (HC)
from Northeast Brazil.
Haplotypes (−52/−44/−20)  TB patients Healthy controls
2n = 572
p-value,  OR (95% CI)
All
2n = 184
pTB
2n = 126
All  vs. HC pTB vs. HC
ACG 86 (0.47) 58 (0.46) 264 (0.46) Reference Reference
GCA 64 (0.35) 42 (0.34) 210 (0.37) p = 0.78, 0.94 (0.63–1.38) p = 0.74, 0.91 (0.57–1.44)
GGG 30 (0.16) 22 (0.18) 80 (0.14) p = 0.61, 1.15 (0.68–1.91) p = 0.47, 1.25 (0.68–2.23)
GCG 4 (0.01) 4 (0.02) 18 (0.03) p = 0.61, 0.68 (0.16–2.15) p = 1.00, 1.01 (0.24–3.23)
pTB, pulmonary tuberculosis; OR, odds ratio; 95% CI, 95% conﬁdence interval; nc, not calculable. Reference indicates the most frequent
haplotypes.
Table 3 – Haplotypes frequencies in healthy individual of different ethnic origin.
Haplotypes Frequencies
Brazilian (BRA) African (AFR) Caucasian (CEU) Ad Mixed
American (AMR)
ACG 0.460 0.588 0.399 0.297
GCA 0.369 0.300 0.354 0.438
64 
49 
rGGG 0.142 0.0
GCG 0.030 0.0
of ancestral allele of −44 SNP (rs1800972) is 0.26 in Euro-
pean (CEU), 0.04 in Sub-Sahara African (YRI) and 0.12 in Asian
(HCB); for −20 SNP (rs11362), the frequency is 0.61 in Euro-
pean (CEU), 0.60 in Sub-Sahara (YRI) and 0.71 in Asian (HCB).
In addition, the SNPs analyzed in Brazilian healthy individuals
and healthy individual of African (AFR), in Caucasian (CEU)
and Ad Mixed American (AMR) origin, were in perfect linkage
disequilibrium (D′ = 1.0) and presented different haplotypic
distribution (Table 3), suggesting that ethnics background may
be responsible for the differences observed in populations that
have been studied. Additionally, in the Han Chinese popula-
tion no linkage disequilibrium was detected (D′ < 0.5)8 and as
a consequence comparing DEFB1 haplotype results with our
ﬁndings has not been possible. Moreover, when looking at the
Mexican population it has to be remarked that the study of
Lopez Campos et al.37 just analyzed one DEFB1 SNP −44C>G
and other SNPs in cathelicidin encoding CAMP gene. So, it was
not possible to compare our DEFB1 haplotypes with the results
reported for Mexican patients. Furthermore, DEFB1 rs1800972
allele and genotype frequencies reported in the Mexican popu-
lation (not in Hardy–Weimberg Equilibrium) were signiﬁcantly
different (0.0002) for the C allele to Brazilian ones.
However, we  cannot exclude, that the lack of association
reported in our study, could be due to the limited sample size;
the power of our study (post hoc Power ≤ 0.5) indicates that not
ﬁnding an association between SNPs with TB development,
could be due to a type II error. This is a strong limitation of
our study, and seeing that also the works of Wu et al.8 and
Lopez Campos et al.37 suffer the same sample size problem, we
are convinced that any further study dealing with association
between defensins gene polymorphism and TB, should enroll
greater number of patients, may be joining several research
groups, in order to achieve better statistical power to provide
a deﬁnitive answer on the role of defensins in susceptibility to
TB.0.000 0.000
0.247 0.261
All this considered, even if our results seem to exclude an
association between DEFB1 polymorphisms and TB develop-
ment in Northeast Brazilian population, since DEFB1 could be a
potential candidate gene for susceptibility to TB and only very
few studies have addressed this topic achieving controversial
results, we do think that further studies on a larger number of
patients and in other populations are needed to disclose the
role of DEFB1 variations in tuberculosis development.
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